| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.076 | 0.2 |